Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Riluzole is an antiexcitotoxic agent used for the treatment of amyotrophic lateral sclerosis, and reported to have neuroprotective effects in animal models of Parkinson's disease, Huntington's disease and brain ischemia. We investigated the effects of riluzole on synthesis of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in cultured mouse astrocytes. The protein and mRNA levels were measured by enzyme-linked immunosorbent assay and semiquantitative reverse transcription-polymerase chain reaction, respectively. Treatment with riluzole at 100 microg/ml (426 microM) for 24 h increased the contents of NGF, BDNF, and GDNF in the culture medium 109-fold, 2.0-fold and 3.1-fold over the control, respectively. The drug-induced relative mRNA levels of NGF, BDNF, and GDNF were 7.3-fold at 2 h, 2.1-fold at 4 h, and 1.9-fold at 2 h, respectively. These results indicate that riluzole stimulates synthesis of NGF, BDNF and GDNF in cultured astrocytes. Riluzole might exert neuroprotective effects, at least in part, via stimulation of neurotrophic factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Riluzole also increases glutamate–glutamine cycling, a potential explanation for in vitro observations of enhanced neuroplasticity and amelioration of excitotoxicity [176,177], as well as in vivo reductions in depressive behaviors [144,178].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [177]
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
The pharmacology and mechanism of action of riluzole
Doble, A. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_4.233s · Cited by 698
Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture
Furukawa, S., Furukawa, Y., Satoyoshi, E., & Hayashi, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90876-4 · Cited by 277
Palfi, S., Ferrante, R. J., Brouillet, E., Beal, M. F., Dolan, R., Guyot, M. C., Peschanski, M., & Hantraye, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-09-03019.1996 · Cited by 261
Benavides, J. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90196-0 · Cited by 207
Mizoule, J., Meldrum, B., Mazadier, M., Croucher, M., Ollat, C., Uzan, A., Legrand, J.-J., Gueremy, C., & Le Fur, G. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90011-5 · Cited by 194
PHARMACOLOGY OF NEUROTROPHIC FACTORS
Hefti, F. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.239 · Cited by 186
Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis
Gurney, M. E., Fleck, T. J., Himes, C. S., & Hall, E. D. (1998) · Neurology · doi:10.1212/wnl.50.1.62 · Cited by 178
Lindsay, R. M. (1995) · Nature · doi:10.1038/373289a0 · Cited by 98
Kordower, J., Isacson, O., & Emerich, D. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7156 · Cited by 91
Cited by
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
“The finding that riluzole upregulates the levels of neuroprotective factors, including BDNF and glial-derived neurotrophic factor (GDNF), has led to extensive reevaluation of this drug in a 3-yr-long clinical trial involving a total of 400 early-symptomatic European patients (394).”
BackgroundRole of brain-derived neurotrophic factor in Huntington's disease
ZUCCATO, C., & CATTANEO, E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.003 · Cited by 552
“Like memantine, riluzole (a neuroprotective drug commonly used in amyotrophic lateral sclerosis (ALS)) acts by blocking glutamatergic neurotransmission in the CNS. Interestingly, it has also been found to upregulate the levels of a number of key neurotrophic factors, including BDNF and glial-derived neurotrophic facto…”
BackgroundInfluentialAstrocyte apoptosis: implications for neuroprotection
Takuma, K., Baba, A., & Matsuda, T. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.001 · Cited by 435
Bellingham, M. C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00116.x · Cited by 388
“In cultured mouse astrocytes, riluzole (100 μM) strongly up-regulated NGF, GDNF, and BDNF mRNA levels [135].”
Background
Metadata
- Authors
- Mizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., & Kuno, S.
- Affiliations
- Utano Hospital (JP)
- Kobe Pharmaceutical University (JP)
- Tokushima University Hospital (JP)
- Corresponding author
- Ohta, Mitsuhiro
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 310
- Issue
- 2-3
- Pages
- 117-120
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2026412461
- Cited by
- 145
- References
- 19
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 6 · 2013: 8 · 2012: 3
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- riluzole, nerve growth factor, brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor, astrocytes, neuroprotection, amyotrophic lateral sclerosis
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, Mice, Inbred ICR, Nerve Growth Factors, Nerve Tissue Proteins, Neuroprotective Agents, Brain-Derived Neurotrophic Factor, Riluzole, Nerve Growth Factor, Glial Cell Line-Derived Neurotrophic Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. https://app.cochat.ai/papers/10.1016/s0304-3940(01)02098-5
- The paper
- Mizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., & Kuno, S. (2001). Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neuroscience Letters. https://doi.org/10.1016/s0304-3940(01)02098-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.